Premier Research is a global contract research organization (CRO) headquartered in the United Kingdom. The company provides a range of clinical development services to pharmaceutical, biotech, and medical device companies worldwide. Founded in 1989, Premier Research initially focused on providing clinical trial services to the pharmaceutical industry.

Over the years, it expanded its capabilities and established itself as a leading CRO with a reputation for delivering high-quality results. The company's headquarters is located in Wokingham, Berkshire, UK. From this central location, Premier Research operates numerous offices globally, including locations in the United States, Canada, Germany, Spain, France, Italy, and China, among others.

Premier Research offers a comprehensive suite of services, including clinical trial management, project and data management, regulatory affairs, safety and pharmacovigilance, and medical affairs. The company specializes in various therapeutic areas, including oncology, neuroscience, infectious diseases, and rare diseases. In terms of global operations, Premier Research has a diverse clientele that includes major pharmaceutical companies, small to mid-size biotech firms, and medical device manufacturers.

The company has also formed notable partnerships and strategic collaborations with other organizations, including academic institutions, contract manufacturing organizations, and clinical trial supply companies. Premier Research has established a strong position in the CRO market. It competes with other global CROs such as QuintilesIMS, ICON plc, and PRA Health Sciences.

While specific sales figures are not publicly available, Premier Research has been successful in securing contracts for clinical trials globally. In recent years, Premier Research has made significant strides in expanding its capabilities and geographical reach. The company has actively pursued acquisitions to enhance its service portfolio and strengthen collaborations with other CROs.

These strategic moves have enabled Premier Research to serve a broader range of clients and provide comprehensive end-to-end solutions for clinical development. As of the latest available information, Premier Research continues to grow and innovate in the CRO industry. The company maintains a client-centric approach, emphasizing quality, efficiency, and personalized solutions.

It remains committed to advancing drug and device development efforts globally and ensuring patient safety in clinical trials